期刊文献+

细菌广谱酶与超广谱酶对头孢噻肟的水解作用及酶抑制剂抑酶效应

Studies on hydrolysis of cefotaxime by broad and extended-spectrum-β-lactamase and inhibitory actions of tazobactam and sulbactam
下载PDF
导出
摘要 目的:观察比较头孢噻肟(CTX)对细菌广谱及超广谱β-内酰胺酶的稳定性以及三唑巴坦(TAZ)和舒巴坦(SBT)的抑酶效应。方法:用超声破碎法提取60株本院附属医院临床分离菌的β-内酰胺酶,用三维试验法检测β-内酰胺酶酶型;用紫外分光光度计检测酶活性及酶对CTX的水解率。结果:60株细菌中产超广谱酶者31株,产广谱酶者29株;两类酶的活性为非正态分布,其中位数分别为3 094 U和528 U(P<0.05)。3种常见菌的酶活性高低依次为大肠埃希菌、阴沟肠杆菌和铜绿假单孢菌(中位数分别为2656 U,1185 U和165.5 U,P<0.05)。超广谱酶对CTX的水解率(中位数20.10%)显著高于广谱酶(中位数3.15%)(P<0.05)。TAZ和SBT均能显著抑制两类酶对CTX的水解作用,但两种酶抑制剂的作用无差异(P>0.05)。结论:超广谱酶(ESBLs)对CTX的水解作用较广谱酶强,TAZ和SBT能有效抑制两类酶对CTX的水解,但其抑制作用强度基本相同。 Objective:To observe the stability of cefotaxime (CTX) to broad-and extended-spectrum β-lactamase, and to compare in- hibiting-β-lactamase activities of tazobactam and sulbactam. Methods: 60 strains of Gram-negative bacilli from Affiliated Hospital of North Sichuan Medical College were dealed with ultrasonic wave and their β-lactamases were extracted and these enzymes were detected by three-dimensional test. β-lactamase activitiy and hydrolysis of CTX were quantitated spectrophotometrically and calculated. Results : In these β-lactamases of 60 strains of Gram-negitive bacilli, the number of extended-spectrum β-lactamases and broad-spectrum β-lactamases were 31 and 29, respectively, and their medians of enzyme activities were 3 094 U and 528 U (P 〈 0.05 ). The medians of β-lactamases activities of Escherichia coli ,Enterobacter cloacae and Pseudomonas aeruginosa were 2 656 U, 1 185 U and 165.5 U, respectively. The median of hydrolysis rates (HR) of CTX by ESBLs and BSBLs were 20.10% and 3.15%, respectively(P 〈0.05). The combination of CTX/TAZ and CTX/SBT (the ratio = 2 : 1 ) could make the HR drop significantly (P 〈 0.05), but the effects of TAZ and SBT were of no differences (P 〉 0.05). Conclusion:The hydrolysis activities of ESBLs on CTX was higher than that of BSBLs. TAZ and SBT could effectively inhibit hydrolysis of CTX by β-lactamases, but these two inhibitors had little difference in their potency.
出处 《药学实践杂志》 CAS 2007年第6期376-378,共3页 Journal of Pharmaceutical Practice
基金 四川省教育厅自然科学重点科研项目(No.2005A081)
关键词 头孢噻肟 三唑巴坦 舒巴坦 超广谱β-内酰胺酶 广谱酶 革兰阴性杆菌 水解 cefotaxime tazobactam sulbactam extended-spectrum β-lactamase broad-spectrum β-lactamase Gram-negative bacilli hydrolysis
  • 相关文献

参考文献13

二级参考文献63

  • 1黎世能,王浴生,雷军.新一代β-内酰胺抗生素对阴沟杆菌β-内酰胺酶的诱导分析[J].中国抗生素杂志,1994,19(5):367-371. 被引量:2
  • 2平松启一.MC-200616 potentiates the activity of β-lactam antibiotics against MRSA[J].日本化学疗法学会杂志,1997,45(9):801-809.
  • 3横田健 鸠田甚五郎 中山一诚 他.インタ-サイヱンス化学疗法会议から [J].感染症,1990,20(1):15-15.
  • 4林泉.二段疗法 [J].化学疗法の领域,1995,11(1):281-281.
  • 5林泉 长谷川浴.抗菌药见直しシリ-ス (9) ホスホマイシン [J].Jpn J Antibiot,1994,47(7):861-861.
  • 6原耕平.新药シンポジウム L- 627 (Biapenem) [J].Che- motherapy,1994,42(5):674-674.
  • 7山口惠三 平松启一 小林芳夫 他.インタ-サイヱンス化学疗法会议から [J].感染症,1995,25(1):20-20.
  • 8[2]Stoward C D,Wallaoo D,Hubort S K,et al.Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE Laboratories [J].Diagn Microbiol Infect Dis, 2000, 38(1):59
  • 9[3]Wu T L,Siu L K,Su L H,et al.Outer membrane protein change combined with CO- existing TEM- 1 and SHV- 1 beta- lactamases lead to false identification of ESBL- producing Klebsiella pneumoniae [J].J Antimicrob Chemother, 2001, 47(16):755
  • 10[4]Pfaller M A,Acar J,Jones R N,et al.Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program[J].Clin Infect Dis, 2001, 32(Suppl 2):156

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部